Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| Immune Design Corp. | 25 000 | déclaré | 07 janv. 2015 | tx 1+25 000 |
| Nivalis Therapeutics, Inc. | 0 | déclaré | 20 mai 2024 | tx 72+1 077 039−1 077 039 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 20 mai 2024 | OTHER | Nivalis Therapeutics, Inc. | 31 200 | — | |
| 20 mai 2024 | OTHER | Nivalis Therapeutics, Inc. | 26 761 | — | |
| 20 mai 2024 | OTHER | Nivalis Therapeutics, Inc. | 108 999 | — | deriv |
| 20 mai 2024 | OTHER | Nivalis Therapeutics, Inc. | 112 500 | — | deriv |
| 20 mai 2024 | OTHER | Nivalis Therapeutics, Inc. | 836 | — | deriv |
| 20 mai 2024 | OTHER | Nivalis Therapeutics, Inc. | 1 214 | — | deriv |
| 20 mai 2024 | OTHER | Nivalis Therapeutics, Inc. | 143 | — | deriv |
| 20 mai 2024 | OTHER | Nivalis Therapeutics, Inc. | 137 | — | deriv |
| 20 mai 2024 | OTHER | Nivalis Therapeutics, Inc. | 78 000 | — | deriv |
| 20 mai 2024 | OTHER | Nivalis Therapeutics, Inc. | 112 945 | — | deriv |
| 07 mai 2024 | EXERCISE | Nivalis Therapeutics, Inc. | 398 | 5.02 USD | |
| 07 mai 2024 | EXERCISE | Nivalis Therapeutics, Inc. | 18 286 | 3.23 USD | |
| 07 mai 2024 | EXERCISE | Nivalis Therapeutics, Inc. | 164 | 11.31 USD | |
| 07 mai 2024 | EXERCISE | Nivalis Therapeutics, Inc. | 857 | 6.51 USD | |
| 07 mai 2024 | EXERCISE | Nivalis Therapeutics, Inc. | 1 | 7.55 USD | |
| 07 mai 2024 | EXERCISE | Nivalis Therapeutics, Inc. | 7 055 | 13.20 USD | |
| 07 mai 2024 | EXERCISE | Nivalis Therapeutics, Inc. | 18 286 | 0.00 USD | deriv |
| 07 mai 2024 | EXERCISE | Nivalis Therapeutics, Inc. | 398 | 0.00 USD | deriv |
| 07 mai 2024 | EXERCISE | Nivalis Therapeutics, Inc. | 1 | 0.00 USD | deriv |
| 07 mai 2024 | EXERCISE | Nivalis Therapeutics, Inc. | 857 | 0.00 USD | deriv |
| 07 mai 2024 | EXERCISE | Nivalis Therapeutics, Inc. | 164 | 0.00 USD | deriv |
| 07 mai 2024 | EXERCISE | Nivalis Therapeutics, Inc. | 7 055 | 0.00 USD | deriv |
| 26 janv. 2024 | SALE | Nivalis Therapeutics, Inc. | 44 000 | 25.00 USD | |
| 26 janv. 2024 | EXERCISE | Nivalis Therapeutics, Inc. | 44 000 | 11.31 USD | |
| 26 janv. 2024 | EXERCISE | Nivalis Therapeutics, Inc. | 73 764 | 6.51 USD |